Gunyana 1 ndiko kutanga kwemwedzi welymphoma uye kubva nhasi mimwe mishonga mitsva miviri yakawedzerwa kuPBS yevarwere velymphoma.
Gurukota rezvehutano reFederal Greg Hunt nguva pfupi yadarika yakazivisa kuti kubva 1st yaGunyana, varwere vanokodzera vekuAustralia vane relapsed / refractory primary mediastinal B cell lymphoma (PMBCL) uye kudzokazve / refractory Chronic Lymphocytic Leukemia (CLL) uye Diki Lymphocytic lymphoma (SLL) ichave itsva. nzira dzekurapa dziripo kwavari paPBS.
PMBCL ishoma shoma ye lymphoma uye varwere vava kukwanisa kuwana Keytruda kana vakadzokera pakurapa kwakare kana kuti vairamba kurapwa. KEYTRUDA (Pembrolizumab) mushonga we immunotherapy unogonesa immune system yemuviri kurwisa lymphoma.
Kuverenga (Acalabrutinib) ichave iripo zvakare paPBS kune vanokodzera varwere veAustralia vane Chronic Lymphocytic Leukemia uye Diki Lymphocytic Lymphoma. Aya lymphoma subtypes anoonekwa segomarara risingaperi sezvo risingapere asi Calquence inopa varwere vanokodzera imwe nzira yekuwedzera yekurapa.
Lymphoma Australia inoda kutenda varwere vese nedzimwe nhengo dzenharaunda dzakatibatsira nekuita kutumira kuPBAC kuitira kuti marapirwo matsva aya atenderwe kune vese vanokodzera varwere.
Kuti uwane rumwe ruzivo uye kutaura kwevezvenhau, ndapota fonera Lymphoma Australia CEO Sharon Winton pa0431 483 204.
